J P M O R G A N North America Equity Research 29 July 2026 Integra LifeSciences Early Read on 2Q26 Results Integra reported mixed 2Q26 results Wednesday morning as the quarter itself was in-line/better than expected, though full year guidance is staying put. Starting with the quarter, sales of $418.8M (+0.7% organic) were in-line with consensus on a reported basis and ahead of consensus organic growth of 0.3% as a modestly better Specialty Surgery (+$3M), which benefitted from order timing, offset a slight ...